These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 6905871)
1. Bioavailability of parenteral drugs I. Intravenous and intramuscular doses. Tse FL; Welling PG J Parenter Drug Assoc; 1980; 34(5):409-21. PubMed ID: 6905871 [No Abstract] [Full Text] [Related]
2. Bioavailability of parenteral drugs II. Parenteral doses other than intravenous and intramuscular routes. Tse FL; Welling PG J Parenter Drug Assoc; 1980; 34(6):484-95. PubMed ID: 6906371 [No Abstract] [Full Text] [Related]
3. [Methodological approach to the measure of the bioavailability of drugs in man (author's transl)]. Lesne M J Pharm Belg; 1976; 31(1):5-24. PubMed ID: 768445 [No Abstract] [Full Text] [Related]
4. [Dosage regimen calculation of "intravenous injection+intravenous infusion" for two compartment model drugs]. Zhang WG Yao Xue Xue Bao; 1983 Aug; 18(8):561-8. PubMed ID: 6677037 [No Abstract] [Full Text] [Related]
6. [Mathematical analysis concerning the dosage regimen of intravenous infusion of two-compartment model drugs (author's transl)]. Zhu JB Yao Xue Xue Bao; 1980 Dec; 15(12):741-9. PubMed ID: 7257801 [No Abstract] [Full Text] [Related]
7. Potentials of chromatographic methods in assessing the bioavailability and the pharmacokinetics of drugs. de Zeeuw RA Pharmazie; 1981 Mar; 36(3):178-84. PubMed ID: 7279981 [No Abstract] [Full Text] [Related]
8. [Bioavailability of drugs--concepts and problems]. Bekemeier H; Hirschelmann R Pharmazie; 1984 Jan; 39(1):59-62. PubMed ID: 6718470 [TBL] [Abstract][Full Text] [Related]
9. Methods for estimating drug bioavailability parameters. Part 3: Peculiarities of pharmacokinetic analysis in assessment of bioavailability. Firsov AA; Piotrovskii VK Pharmazie; 1986 Jul; 41(7):457-65. PubMed ID: 3534896 [No Abstract] [Full Text] [Related]
10. [Pharmacokinetics of double-bottle intravenous infusion]. Song JG; Sun RY Yao Xue Xue Bao; 1983 Oct; 18(10):732-40. PubMed ID: 6677028 [No Abstract] [Full Text] [Related]
11. [Bioavailability and biopharmaceutics]. Colombo BM; Colombo MM; De Fusco R Boll Chim Farm; 1976 Mar; 115(3):231-41. PubMed ID: 1275980 [No Abstract] [Full Text] [Related]
12. [Drugs and the organism. II. Bioavailability]. Pflegel P; Pfeifer S Pharmazie; 1980; 34(5-6):337-59. PubMed ID: 6893363 [No Abstract] [Full Text] [Related]
13. [Optimization of bioavailability of pharmacons]. Kata M; Aigner Z; Erös I Acta Pharm Hung; 1998 Mar; 68(2):107-11. PubMed ID: 9592935 [TBL] [Abstract][Full Text] [Related]
14. Bioavailability of drugs. Maitai CK East Afr Med J; 1982 Aug; 59(8):503-4. PubMed ID: 7173083 [No Abstract] [Full Text] [Related]
15. [Exponential infusion and its pharmacokinetics]. Huang SK; Meng X Zhongguo Yao Li Xue Bao; 1982 Sep; 3(3):199-204. PubMed ID: 6216731 [No Abstract] [Full Text] [Related]
16. [Diurnal rhythm of the biological availability of drugs]. Markiewicz A Pol Tyg Lek; 1983 Mar; 38(10):305-8. PubMed ID: 6683404 [No Abstract] [Full Text] [Related]
17. [Studies of the pH of drugs administered parenterally]. Zietkiewicz W; Kostrzewska E Pol Tyg Lek; 1971 Jun; 26(25):937-9. PubMed ID: 5564508 [No Abstract] [Full Text] [Related]
18. [Bioavailability of drugs]. Finzi GF; Riolo U; Ghini R Arch Sci Med (Torino); 1982; 139(1):51-5. PubMed ID: 7103709 [No Abstract] [Full Text] [Related]
19. [Presystemic elimination and biological availability of drugs]. Klotz U Med Lab (Stuttg); 1981; 34(7-8):171-6. PubMed ID: 7311931 [No Abstract] [Full Text] [Related]
20. Analysis of the results of bioavailability studies of different drugs in humans. Wichliński LM; Kanarkowski R; Krzyśko K Acta Pol Pharm; 1986; 43(3):276-82. PubMed ID: 3788627 [No Abstract] [Full Text] [Related] [Next] [New Search]